abstract |
The present invention relates to a method for treating or preventing a PPAR-η mediated disease or condition comprising administration of a therapeutically effective amount of FMOC-L-Leucine or derivatives thereof, of the formula I: Said method is particularly useful for treating or preventing anorexia, hyperlypidemia, insulin resistance, inflammatory diseases, cancer and sking disorders. |